Global Sialylated Human Milk Oligosaccharides (HMO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 99

Published Date: 07 Feb 2024

Category: Food & Beverages

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Sialylated Human Milk Oligosaccharides (HMO) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3’-Sialyllactose (3’-SL) and 6′-sialyllactose (6’-SL) are two simplest sialylated HMOs. The global market for Human Milk Oligosaccharides (HMO) was estimated to be worth US$ 467.7 million in 2023 and is forecast to a readjusted size of US$ 1227.5 million by 2030 with a CAGR of 14.5% during the forecast period 2024-2030.

The Global Info Research report includes an overview of the development of the Sialylated Human Milk Oligosaccharides (HMO) industry chain, the market status of Infant Formula (3'-Sialyllactose, 6'-Sialyllactose), Food (3'-Sialyllactose, 6'-Sialyllactose), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Sialylated Human Milk Oligosaccharides (HMO).

Regionally, the report analyzes the Sialylated Human Milk Oligosaccharides (HMO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Sialylated Human Milk Oligosaccharides (HMO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Sialylated Human Milk Oligosaccharides (HMO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Sialylated Human Milk Oligosaccharides (HMO) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., 3'-Sialyllactose, 6'-Sialyllactose).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Sialylated Human Milk Oligosaccharides (HMO) market.

Regional Analysis: The report involves examining the Sialylated Human Milk Oligosaccharides (HMO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Sialylated Human Milk Oligosaccharides (HMO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Sialylated Human Milk Oligosaccharides (HMO):
Company Analysis: Report covers individual Sialylated Human Milk Oligosaccharides (HMO) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Sialylated Human Milk Oligosaccharides (HMO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infant Formula, Food).

Technology Analysis: Report covers specific technologies relevant to Sialylated Human Milk Oligosaccharides (HMO). It assesses the current state, advancements, and potential future developments in Sialylated Human Milk Oligosaccharides (HMO) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Sialylated Human Milk Oligosaccharides (HMO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Sialylated Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
3'-Sialyllactose
6'-Sialyllactose

Market segment by Application
Infant Formula
Food
Others

Major players covered
Chr. Hansen (Jennewein Biotechnologie GmgH)
DSM (Glycom A/S)
Inbiose
Kyowa Hakko Bio
GeneChem Inc.
FrieslandCampina Ingredients

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sialylated Human Milk Oligosaccharides (HMO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sialylated Human Milk Oligosaccharides (HMO), with price, sales, revenue and global market share of Sialylated Human Milk Oligosaccharides (HMO) from 2019 to 2024.
Chapter 3, the Sialylated Human Milk Oligosaccharides (HMO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sialylated Human Milk Oligosaccharides (HMO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Sialylated Human Milk Oligosaccharides (HMO) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sialylated Human Milk Oligosaccharides (HMO).
Chapter 14 and 15, to describe Sialylated Human Milk Oligosaccharides (HMO) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Sialylated Human Milk Oligosaccharides (HMO)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 3'-Sialyllactose
        1.3.3 6'-Sialyllactose
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Infant Formula
        1.4.3 Food
        1.4.4 Others
    1.5 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size & Forecast
        1.5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity (2019-2030)
        1.5.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
        2.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Details
        2.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Major Business
        2.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
        2.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments/Updates
    2.2 DSM (Glycom A/S)
        2.2.1 DSM (Glycom A/S) Details
        2.2.2 DSM (Glycom A/S) Major Business
        2.2.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
        2.2.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 DSM (Glycom A/S) Recent Developments/Updates
    2.3 Inbiose
        2.3.1 Inbiose Details
        2.3.2 Inbiose Major Business
        2.3.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product and Services
        2.3.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Inbiose Recent Developments/Updates
    2.4 Kyowa Hakko Bio
        2.4.1 Kyowa Hakko Bio Details
        2.4.2 Kyowa Hakko Bio Major Business
        2.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product and Services
        2.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Kyowa Hakko Bio Recent Developments/Updates
    2.5 GeneChem Inc.
        2.5.1 GeneChem Inc. Details
        2.5.2 GeneChem Inc. Major Business
        2.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product and Services
        2.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 GeneChem Inc. Recent Developments/Updates
    2.6 FrieslandCampina Ingredients
        2.6.1 FrieslandCampina Ingredients Details
        2.6.2 FrieslandCampina Ingredients Major Business
        2.6.3 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product and Services
        2.6.4 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 FrieslandCampina Ingredients Recent Developments/Updates

3 Competitive Environment: Sialylated Human Milk Oligosaccharides (HMO) by Manufacturer
    3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2019-2024)
    3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Sialylated Human Milk Oligosaccharides (HMO) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Sialylated Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2023
        3.4.2 Top 6 Sialylated Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2023
    3.5 Sialylated Human Milk Oligosaccharides (HMO) Market: Overall Company Footprint Analysis
        3.5.1 Sialylated Human Milk Oligosaccharides (HMO) Market: Region Footprint
        3.5.2 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
        3.5.3 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region
        4.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2030)
        4.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2030)
        4.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2019-2030)
    4.2 North America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
    4.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
    4.4 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
    4.5 South America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
    4.6 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
    5.2 Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2030)
    5.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
    6.2 Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2030)
    6.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2030)

7 North America
    7.1 North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
    7.2 North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
    7.3 North America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
        7.3.1 North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
        7.3.2 North America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
    8.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
    8.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
        8.3.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
        8.3.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region
        9.3.1 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
    10.2 South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
    10.3 South America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
        10.3.1 South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
        10.3.2 South America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
        11.3.1 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
    12.2 Sialylated Human Milk Oligosaccharides (HMO) Market Restraints
    12.3 Sialylated Human Milk Oligosaccharides (HMO) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Sialylated Human Milk Oligosaccharides (HMO) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Sialylated Human Milk Oligosaccharides (HMO)
    13.3 Sialylated Human Milk Oligosaccharides (HMO) Production Process
    13.4 Sialylated Human Milk Oligosaccharides (HMO) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Sialylated Human Milk Oligosaccharides (HMO) Typical Distributors
    14.3 Sialylated Human Milk Oligosaccharides (HMO) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Chr. Hansen (Jennewein Biotechnologie GmgH) Basic Information, Manufacturing Base and Competitors
    Table 4. Chr. Hansen (Jennewein Biotechnologie GmgH) Major Business
    Table 5. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    Table 6. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments/Updates
    Table 8. DSM (Glycom A/S) Basic Information, Manufacturing Base and Competitors
    Table 9. DSM (Glycom A/S) Major Business
    Table 10. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    Table 11. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. DSM (Glycom A/S) Recent Developments/Updates
    Table 13. Inbiose Basic Information, Manufacturing Base and Competitors
    Table 14. Inbiose Major Business
    Table 15. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    Table 16. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Inbiose Recent Developments/Updates
    Table 18. Kyowa Hakko Bio Basic Information, Manufacturing Base and Competitors
    Table 19. Kyowa Hakko Bio Major Business
    Table 20. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    Table 21. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Kyowa Hakko Bio Recent Developments/Updates
    Table 23. GeneChem Inc. Basic Information, Manufacturing Base and Competitors
    Table 24. GeneChem Inc. Major Business
    Table 25. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    Table 26. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. GeneChem Inc. Recent Developments/Updates
    Table 28. FrieslandCampina Ingredients Basic Information, Manufacturing Base and Competitors
    Table 29. FrieslandCampina Ingredients Major Business
    Table 30. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    Table 31. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. FrieslandCampina Ingredients Recent Developments/Updates
    Table 33. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Manufacturer (2019-2024) & (Tons)
    Table 34. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 35. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2019-2024) & (US$/Kg)
    Table 36. Market Position of Manufacturers in Sialylated Human Milk Oligosaccharides (HMO), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 37. Head Office and Sialylated Human Milk Oligosaccharides (HMO) Production Site of Key Manufacturer
    Table 38. Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
    Table 39. Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
    Table 40. Sialylated Human Milk Oligosaccharides (HMO) New Market Entrants and Barriers to Market Entry
    Table 41. Sialylated Human Milk Oligosaccharides (HMO) Mergers, Acquisition, Agreements, and Collaborations
    Table 42. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2024) & (Tons)
    Table 43. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2025-2030) & (Tons)
    Table 44. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
    Table 45. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
    Table 46. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2019-2024) & (US$/Kg)
    Table 47. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2025-2030) & (US$/Kg)
    Table 48. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
    Table 49. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
    Table 50. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2024) & (USD Million)
    Table 51. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Type (2025-2030) & (USD Million)
    Table 52. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2024) & (US$/Kg)
    Table 53. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2025-2030) & (US$/Kg)
    Table 54. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
    Table 55. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
    Table 56. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2024) & (USD Million)
    Table 57. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Application (2025-2030) & (USD Million)
    Table 58. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2024) & (US$/Kg)
    Table 59. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2025-2030) & (US$/Kg)
    Table 60. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
    Table 61. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
    Table 62. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
    Table 63. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
    Table 64. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2024) & (Tons)
    Table 65. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2025-2030) & (Tons)
    Table 66. North America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
    Table 67. North America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
    Table 68. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
    Table 69. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
    Table 70. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
    Table 71. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
    Table 72. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2024) & (Tons)
    Table 73. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2025-2030) & (Tons)
    Table 74. Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
    Table 75. Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
    Table 76. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
    Table 77. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
    Table 78. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
    Table 79. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
    Table 80. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2024) & (Tons)
    Table 81. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2025-2030) & (Tons)
    Table 82. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
    Table 83. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
    Table 84. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
    Table 85. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
    Table 86. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
    Table 87. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
    Table 88. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2024) & (Tons)
    Table 89. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2025-2030) & (Tons)
    Table 90. South America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
    Table 91. South America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
    Table 92. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
    Table 93. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
    Table 94. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
    Table 95. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
    Table 96. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2024) & (Tons)
    Table 97. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2025-2030) & (Tons)
    Table 98. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
    Table 99. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
    Table 100. Sialylated Human Milk Oligosaccharides (HMO) Raw Material
    Table 101. Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO) Raw Materials
    Table 102. Sialylated Human Milk Oligosaccharides (HMO) Typical Distributors
    Table 103. Sialylated Human Milk Oligosaccharides (HMO) Typical Customers
List of Figures
    Figure 1. Sialylated Human Milk Oligosaccharides (HMO) Picture
    Figure 2. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type in 2023
    Figure 4. 3'-Sialyllactose Examples
    Figure 5. 6'-Sialyllactose Examples
    Figure 6. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application in 2023
    Figure 8. Infant Formula Examples
    Figure 9. Food Examples
    Figure 10. Others Examples
    Figure 11. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity (2019-2030) & (Tons)
    Figure 14. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price (2019-2030) & (US$/Kg)
    Figure 15. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Manufacturer in 2023
    Figure 16. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Manufacturer in 2023
    Figure 17. Producer Shipments of Sialylated Human Milk Oligosaccharides (HMO) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 18. Top 3 Sialylated Human Milk Oligosaccharides (HMO) Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Top 6 Sialylated Human Milk Oligosaccharides (HMO) Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Region (2019-2030)
    Figure 21. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
    Figure 22. North America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
    Figure 23. Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
    Figure 24. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
    Figure 25. South America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
    Figure 26. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
    Figure 27. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
    Figure 28. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type (2019-2030)
    Figure 29. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2030) & (US$/Kg)
    Figure 30. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
    Figure 31. Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application (2019-2030)
    Figure 32. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2030) & (US$/Kg)
    Figure 33. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
    Figure 34. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
    Figure 35. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Country (2019-2030)
    Figure 36. North America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Canada Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Mexico Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
    Figure 41. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
    Figure 42. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Country (2019-2030)
    Figure 43. Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
    Figure 44. Germany Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. France Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. United Kingdom Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Russia Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Italy Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
    Figure 50. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
    Figure 51. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Region (2019-2030)
    Figure 52. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
    Figure 53. China Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Japan Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Korea Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. India Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Australia Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
    Figure 60. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
    Figure 61. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Country (2019-2030)
    Figure 62. South America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
    Figure 63. Brazil Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Argentina Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
    Figure 66. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
    Figure 67. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Region (2019-2030)
    Figure 68. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
    Figure 69. Turkey Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Egypt Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. South Africa Sialylated Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
    Figure 74. Sialylated Human Milk Oligosaccharides (HMO) Market Restraints
    Figure 75. Sialylated Human Milk Oligosaccharides (HMO) Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Sialylated Human Milk Oligosaccharides (HMO) in 2023
    Figure 78. Manufacturing Process Analysis of Sialylated Human Milk Oligosaccharides (HMO)
    Figure 79. Sialylated Human Milk Oligosaccharides (HMO) Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Chr. Hansen (Jennewein Biotechnologie GmgH)
DSM (Glycom A/S)
Inbiose
Kyowa Hakko Bio
GeneChem Inc.
FrieslandCampina Ingredients

Related Reports

Global Sialylated Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2024-2030

Global Sialylated Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2024-2030

date 07 Feb 2024

date Food & Beverages

The global Sialylated Human Milk Oligosaccharides (HMO) market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Sialylated Human Milk Oligosaccharides (HMO)

Vegetarian No-fat Cake

Dairy Flavor Spices

Cake

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>